Do's and don'ts in the US: the secrets of success from start-up to unicorn
Posted on: 31/01/2018
Over the past 20 years, Idinvest has supported through its venture capital activity a large number of European start-ups, many of whom have almost inevitably managed to gain a foothold in the US.
Such has been the case for Talend and Criteo, two French start-ups that have gone from receiving seed funding to being listed on the NASDAQ exchange in New York, both with a market capitalisation exceeding $1 billion.
Bertrand Diard, CEO of Talend; Yann Fleureau, CEO of Cardiologs; and Johanna Ponte, HR manager at Botify and former Head of Compliance at Criteo, all took part in a workshop during which they gave their feedback on which steps to take and which to avoid for start-ups looking to develop across the pond.